Teplizumab

Records for this ingredient, by country (identity only).

ATC A10XX01 · 6 markets · 7 records

Teplizumab 6 markets · 7 records Forms
Filters

AU 2 records · 1 shown of 1 Source TGA、TGA CMI repository (consumer medic · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

  • 2 mg per mL / per unit basis not statedinjectionTZIELD teplizumab 2 mg/2 mL Concentrated injection vial unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

US 1 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 1 mg per mL / per unit basis not statedinjectionTZIELD

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 2 mg/2 mLinjectionTzield 2mg/2ml concentrate for solution for infusion vials

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.